Pseudoseptic reactions to hylan viscosupplementation - Diagnosis and treatment

被引:79
作者
Goldberg, VM
Coutts, RD
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.1097/01.blo.0000116314.20130.11
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Hyaluronans are used widely in the treatment of osteoarthritis of the knee. Three commercial hyaluronan preparations currently are available in the United States: sodium hyaluronate (Hyalgan), sodium hyaluronate (Supartz), and hylan G-F 20 (Synvisc). Although the sodium hyaluronates are derived naturally, hylan is chemically modified to increase its molecular weight. All three products have been shown to be well tolerated in clinical trials, however, there have been reports in the literature of pseudoseptic reactions, or severe acute inflammatory reactions, after injections with hylan. Our study reviewed the reported incidence of pseudosepsis. The pathogenic mechanisms and clinical treatment of this reaction are presented.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 55 条
[1]
Abatangelo G., 1995, European Journal of Rheumatology and Inflammation, V15, P9
[2]
Adams ME, 1996, J RHEUMATOL, V23, P944
[3]
A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee [J].
Adams, ME ;
Lussier, AJ ;
Peyron, JG .
DRUG SAFETY, 2000, 23 (02) :115-130
[4]
Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid [J].
Ali, Y ;
Weinstein, M ;
Jokl, P .
AMERICAN JOURNAL OF MEDICINE, 1999, 107 (06) :641-642
[5]
Allen E, 2000, J RHEUMATOL, V27, P1572
[6]
Altman RD, 1998, J RHEUMATOL, V25, P2203
[7]
[Anonymous], 2000, ARTHRITIS RHEUM, V23, P115
[8]
Balazs E, 1992, U.S. Patent, Patent No. 5099013
[9]
MATRIX ENGINEERING [J].
BALAZS, EA ;
BLAND, PA ;
DENLINGER, JL ;
GOLDMAN, AI ;
LARSEN, NE ;
LESHCHINER, EA ;
LESHCHINER, A ;
MORALES, B .
BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) :173-178
[10]
BALAZS EA, 1993, J RHEUMATOL, V20, P3